Pfizer: Nonalcoholic steatohepatitis (NASH) Non-invasive Diagnosis (Global)
| Name: |
Pfizer: Nonalcoholic steatohepatitis (NASH) Non-invasive Diagnosis (Global) Application deadline: 30/07/20 |
|---|---|
| General description: |
Proposals should aim to advance the discussion around non-invasive biomarkers and diagnostic tools for NASH. Funding: up to $250K. https://pfe-pfizercom-prod.s3.amazonaws.com/GMG_NASHdiagnosis.pdf
|
| Source: | Foreign |
| Participating Countries: | All Countries, |
| Budget: | Funding: up to $250K. |
| Contact person: | Robi, 2152, robertg@ttechnion.ac.il |
| Fields: | Life Sciences and medicine |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | Pfizer ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |